<DOC>
	<DOCNO>NCT01368783</DOCNO>
	<brief_summary>Compared Caucasians , plasma level atazanavir ( ATV ) may high Koreans dosage regimen ( ) . If , even unboosted ATV could use tenofovir DF ( TDF ) lower concentration ATV . The investigator plan investigate pharmacokinetic feature ATV without TDF healthy Korean Caucasian volunteer compare ethnic difference .</brief_summary>
	<brief_title>Two Clinical Trials Evaluate Pharmacokinetics Unboosted Boosted Atazanavir Used Alone Co-administered With Tenofovir DF Healthy Korean Caucasian Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Atazanavir Sulfate</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<criteria>Men age 20 55 year old , weight 50 kg appropriate body mass index ( BMI ) value within 1928 kg/m2 . Agreed voluntarily participate study comply study protocol write permission . Has history liver , kidney , respiratory , musculoskeletal , endocrinologic , neuropsychiatric , hematooncologic , cardiovascular problem ( ) . Has history hypersensitivity clinically significant adverse drug reaction ( ) study drug , class study drug , drug include aspirin antibiotic . Drinks excessive caffeinated beverage ( caffeine &gt; 10 units/day ) , alcohol beverage ( alcohol &gt; 21 units/week ) smoke excessively ( &gt; 20 cigarettes/day ) history alcoholism . Has exclude researcher due abnormal finding screen EKG and/or blood test</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>